Headlines Flash
Wed, Jun 10 07:02 AM

🏷️ #acquisition

6 headlines
BusinessGuardian US18h ago

GSK makes biggest ever acquisition with $10.6bn for US cancer drug firm

Nuvalent’s late-stage lung cancer treatments zidesamtinib and neladalkib are expected to launch later this year Business live – latest updates GSK’s new boss, Luke Miels , has struck one of the British drugmaker’s biggest deals, announcing the $10. 6bn (£7. 9bn) acquisition of a US cancer special...